Menu

Genetic Nondiscrimination in Canada

Canada’s parliament is set for a final vote on a proposed genetic nondiscrimination act.

Mar 9, 2017
Joshua A. Krisch

WIKIMEDIA, SAFFRON BLAZECanada’s parliament threw its support behind bill S-201, legislation similar to the U.S. Genetic Information Nondiscrimination Act (GINA), which would fine insurers and employers for making decisions based on the results of genetic testing alone, according to The Hill Times. The bill passed a “third reading” on Wednesday night (March 8), the final chance for the House of Commons to debate its contents. The legislation will now return to the Senate for what many hope will be a final vote.

See “Protecting Patients from Genetic Discrimination

Under bill S-201, it would be illegal to force Canadian citizens to undergo genetic testing or provide results to insurance companies or employers. As with GINA, the main opposition is that the bill would be a blow to insurance companies and could raise premiums across the board, if insurers are required to assume more risk. Prime Minister Justin Trudeau has opposed the bill, telling reporters that “one of the elements in the proposed bill is unconstitutional,” according to Global News.

Specifically, some members of Trudeau’s Liberal Party believe the bill is an act of government overreach. They have proposed taking less drastic steps, such as amending the Canadian Human Rights Act to prohibit discrimination based on genetics in place of passing new legislation.

Advocates of genetic nondiscrimination legislation have said that insurance companies shouldn’t be using genetic information alone to make decisions anyway. “Genetic testing is being applied quite broadly without us necessarily understanding the implications clinically,” Shubhayan Sanatani of the British Columbia Children’s Hospital told The Scientist earlier this month.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!